Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-22 · accession 0002009762-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Budur Kumar | Chief MEDICAL Off | M - OptEx | $0.00 | +4,850 | 2,662 | New | $0 |
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Budur Kumar | Chief MEDICAL Off | F - Tax | $36.82 | -2,525 | 1,035 | -71% | -$93.0K |
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Budur Kumar | Chief MEDICAL Off | M - OptEx | $0.00 | -4,850 | 7,988 | -38% | $0 |
| DM | 2026-01-26 | 2026-01-22 | HRMY | Budur Kumar | Chief MEDICAL Off | A - Grant | $0.00 | +54.8K | 42.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-24 | M | A | 2,188 | $0.00 | 2,188 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-25 | F | D | 1,372 | $36.82 | 1,290 | D | — | — | (F1) Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
| 3 | Common | Common Stock | 2026-01-25 | M | A | 2,662 | $0.00 | 2,662 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-24 | F | D | 1,153 | $36.82 | 1,035 | D | — | — | (F1) Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
| 5 | Derivative | Restricted Stock Units | 2026-01-24 | M | D | 2,188 | $0.00 | 4,175 | D | — · — to — | 2,188 Common Stock | (F4) This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2026-01-22 | A | A | 12,200 | $0.00 | 12,200 | D | — · — to — | 12,200 Common Stock | (F3) The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
| 7 | Derivative | Stock Option | 2026-01-22 | A | A | 42,600 | $0.00 | 42,600 | D | $36.76 · — to 2036-01-22 | 42,600 Common Stock | (F2) The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
| 8 | Derivative | Restricted Stock Units | 2026-01-25 | M | D | 2,662 | $0.00 | 7,988 | D | — · — to — | 2,662 Common Stock | (F5) This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |